Pharmaceutical News
Sanofi's Merial acquires animal health division of Dosch
Kolkata, June 14 : Drugmaker Sanofi Friday said its animal health division Merial has completed acquisition of the animal health division of Dosch Pharmaceuticals to enter India's growing animal health market....
Full StoryNew Delhi, June 7 : Backing pharma major Ranbaxy, who has been accused of marketing sub-standard medicines, the health ministry Friday said there was nothing wrong with the quality of its drugs....
Full StoryPIL seeks ban on Ranbaxy drugs
New Delhi, June 5 : A Public Interest Litigation (PIL) petition was filed in the Supreme Court on Wednesday seeking the ban of drugs made by Ranbaxy Laboratories and accusing its Directors of manufacturing and selling adulterated drugs....
Full StoryZydus announces breakthrough with LIPAGLYN
New Delhi, June 5 : Pharma major Zydus Group announced a breakthrough in its research efforts with Lipaglyn (Saroglitazar), a novel drug targeted at bridging an unmet healthcare need for treating Diabetic Dyslipidemia or Hypertriglyceridemia in Type II diabetes, not controlled by statins alone....
Full StoryRanbaxy to pay $500 mn to settle US fraud charges
Washington, May 14 : A subsidiary of Indian generic drug-maker Ranbaxy Laboratories has pleaded guilty to federal charges of selling adulterated drugs with intent to defraud and agreed to pay $500 million to resolve false claim allegations....
Full StoryLupin manages significant cost reductions
New Delhi, May 13 : Lupin Limited, one of the fastest growing pharmaceutical companies, recently deployed Microsoft Office 365 to simplify employee communication, gain business insights and share experiences across its offices in four continents....
Full StoryVenus Remedies honoured for designing Elores
Chandigarh, May 6 : Global pharmaceutical company, Venus Remedies Limited, was awarded the Gold Medal by DST-Lockheed Martin India Innovation Growth Program - 2013 for developing a drug 'Elores' to fight multi-drug resistant ESBL and MBL producing gram negative ICU infections to which other antibiotics have failed to respond....
Full StoryVenus signs deal with Korean pharma
Chandigarh, May 2: Research based pharmaceutical company, Venus Remedies Limited, on Thursday announced signing of its deal with Korean pharma giant Goodwills Co....
Full StoryFortis to launch its flagship hospital tomorrow in Gurgaon
New Delhi, Apr 30 : Fortis Healthcare Limited(Fortis), one of the country's private healthcare chains, will launch its flagship hospital, the 'Fortis Memorial Research Institute(FMRI)',tomorrow in Gurgaon....
Full StoryMumbai to host pharma convention
Mumbai, April 16 : The Pharmaceuticals Export Promotion Council of India (Pharmexcil) will host a three-day pharma convention from April 24, an official said Tuesday....
Full StorySami Labs takes Indian herbal medicine to the world
By Fakir Balaji, Bangalore, April 15 : In a world dominated by allopathic multinationals and their smart marketing strategies, a little-known Indian company in this tech hub has made inroads into the global healthcare sector, focusing on research and development (R&D) in herbal medicines....
Full StoryNovartis ruling sifts 'artful' patent from innovation
By Rohit Bansal : India's apex court is in the witness box facing not-so-subtle protests from the $56.67-billion Swiss drugs giant Novartis that is on the losing side of a far-reaching ruling this week on the crucial area of innovation, research and development in life-saving pharmaceuticals....
Full StoryNovartis loses patent battle, experts hail court ruling
New Delhi, April 1 : In a ruling lauded by health experts and activists, the Supreme Court Monday dismissed Swiss pharma giant Novartis AG's petition seeking patent protection for its anti-cancer drug Glivec (Imatinib Mesylate)....
Full StoryG.V. Prasad appointed Dr Reddy's chairman
Hyderabad, April 1 : Pharma major Dr. Reddy's Laboratories Ltd Monday named its vice-chairman and CEO G.V. Prasad as the new chairman and CEO, succeeding founder chairman K. Anji Reddy, who died last month....
Full StorySC rejection of patent plea discouraging: Novartis
Mumbai, April 1 : As the Supreme Court dismissed Swiss pharmaceutical chain Novartis AG's petition seeking patent protection for its anti-cancer drug, the company Monday said that it will discourage future innovation in India....
Full StoryNovartis calls SC ruling 'disappointing'
Mumbai, Apr 1 : Swiss pharma giant Novartis on Monday said the Supreme Court's decision to dismiss its plea for patenting a cancer drug was 'disappointing'....
Full StoryHealth experts applaud SC ruling on Norvartis
New Delhi, April 1 : Health experts welcomed the landmark ruling of the Supreme Court Monday, rejecting Swiss drugmaker Novartis AG's attempt to patent its cancer drug, saying the dictum would ensure that patients get access to cheaper life-saving drugs....
Full StorySupreme Court rejects patent protection for Novartis cancer drug
New Delhi, April 1 : The Supreme Court Monday dismissed Swiss pharmaceutical chain Novartis AG's petition seeking patent protection for its anti-cancer drug, Glivec (Imatinib mesylate)....
Full StoryNovartis loses patent battle in Supreme Court
New Delhi, Apr 1 : The Supreme Court on Monday dealt a blow to Swiss pharma giant Novartis by dismissing its plea for patenting a cancer drug, after a seven year legal fight, heralding far reaching consequences for patients looking for cheaper drugs and generic drug manufacturers....
Full StoryVenus launches its first OTC product 'Ezenus'
Chandigarh, Mar 25 : Venus Remedies Limited, a research based global pharmaceutical company, on Monday announced the launch of its first OTC (Over-The-Counter) product 'Ezenus', a stress reliever....
Full Story